The field of cardiovascular medicine has been an exemplary partner with the FDA

Entering  new era in medicine characterized by dramatic accelerations in biological and information sciences and near-ubiquitous uptake of social media and personal devices

Need for integration of complex measurement and decision support with traditional devices, drugs, and biologics. Must involve entire ecosystem of which the FDA is a part. Efforts in:

  • Evidence Generation
  • Phenotyping
  • Integrative Biomarkers And Monitoring
  • Targeted Therapy
  • Devices
  • Regenerative Medicine
  • Nutrition And Diet
  • Lifecycle
  • Disparities